The AM404 + GSK126 was significantly more effective in induction of melanoma cell death compared to the single agents and to PLX4720 (Fig. 6a, b) and these results were confirmed in 6 additional BRAF-mutant cell lines (Supplementary Fig. S19b). This evidence concerns the gene BRAF and melanoma.